Following the news from Switzerland
Provided by AGPStay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
EIN Presswire
GUANGZHOU, CHINA, May 19, 2026 /EINPresswire.com/ -- In April 2026, Diode Machining, a premier provider of precision components, announces the strategic expansion of its High-Precision Swiss Machining Services for Metal Shafts, setting a new...
GlobeNewswire, Inc.
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient...
GlobeNewswire, Inc.
BASEL, Switzerland, May 19, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...
EIN Presswire
Driving Industrial Automation with Safety, Reliability, and Precision CALIFORNIA, CA, UNITED STATES, May 19, 2026 /EINPresswire.com/ -- Wenzhou, Zhejiang,May 19, 2026——The industrial control pendant—often referred to as a pendant control...
GlobeNewswire, Inc.
EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...
GlobeNewswire, Inc.
IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment.
GlobeNewswire, Inc.
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease, having met the primary endpoint, reductions in lesion growth rate, in the pivotal, global Phase 3 DRAGON trial Company recently initiated a...
EIN Presswire
NEW YORK, NY, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- The American Swiss Foundation (ASF) hosted its 81st Annual Gala on Tuesday, May 12th, at the Harvard Club in New York City, honoring Andreas Berger, Group Chief Executive Officer of...
GlobeNewswire, Inc.
Key highlights from the first quarter of operations under the expanded management team include the following: Anticipated FDA decision on the Company's ANDA for Preservative-Free Ketamine in Q3 2026, with favorable preliminary determinations...
EIN Presswire
Global Health Leaders Call for Suicide Prevention to be Embedded in AI Chatbots and Online Safety Policy GENEVA, DC, UNITED STATES, May 17, 2026 /EINPresswire.com/ -- Health leaders are calling for suicide prevention to be embedded in artificial...
GlobeNewswire, Inc.
DUBLIN, May 20, 2026 (GLOBE NEWSWIRE) -- AMEC, the International Association for the Measurement and Evaluation of Communication, has launched the AMEC GEO Principles and a companion resource, A Practitioner’s Guide to GEO Measurement, to help...
EIN Presswire
Geneva's Watches and Wonders fair drew 60,000 visitors as Swiss watch exports face headwinds from tariffs and conflict.
GlobeNewswire, Inc.
BANGKOK, May 20, 2026 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC) recently returned to the Klong Toey community to reinforce its partnership with the Duang Prateep Foundation (Slum Child Care Foundation - FSCC), moving beyond traditional...
GlobeNewswire, Inc.
SUMMARY: Preferred Hotels & Resorts has launched Preferred Wellbeing, a new global designation spotlighting more than 50 hotels delivering immersive, holistic wellness experiences.
GlobeNewswire, Inc.
WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today...
GlobeNewswire, Inc.
Reports first quarter 2026 total revenue of $8.0 million, representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first quarter of 2025 First quarter 2026...
GlobeNewswire, Inc.
Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents, restricted cash and capital commitments...
GlobeNewswire, Inc.
JERSEY, Channel Islands — May 19, 2026 — CoinShares PLC (Nasdaq: CSHR) (“CoinShares” or the “Company”), a leading global asset manager specialising in digital assets, today announced that President and Chief Executive Officer Jean-Marie Mognetti...
GlobeNewswire, Inc.
LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- Outdoor Innovation, the industry’s most robust recognition platform for the innovators and leaders of the Outdoor and Sports Recreation Industry, today announced that PROVUU, makers of outdoor wearable...
GlobeNewswire, Inc.
NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEX: 0800), a global leader in autonomous driving technology, today announced its unaudited financial results for the first quarter ended March 31,...
Sign up for:
The daily local news briefing you can trust. Every day. Subscribe now.
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
is already signed up. Check your inbox for updates.